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Abstract Liver mitochondrial bioenergetics of Goto-Kakizaki
(GK) rats (a model of non-insulin dependent diabetes mellitus)
reveals a v8 upon energization with succinate significantly
increased relatively to control animals. The repolarization rate
following ADP phosphorylation is also significantly increased in
GK mitochondria in parallel with increased ATPase activity. The
increase in the repolarization rate and ATPase activity is
presumably related to an improved efficiency of F0F1-ATPase,
either from a better phosphorylative energy coupling or as a
consequence of an enlarged number of catalytic units. Titrations
with oligomycin indicate that diabetic GK liver mitochondria
require excess oligomycin pulses to completely abolish phospho-
rylation, relative to control mitochondria. Therefore, accepting
that the number of operational ATP synthase units is inversely
proportional to the amount of added oligomycin, it is concluded
that liver mitochondria of diabetic GK rats are provided with
extra catalytic units relative to control mitochondria of normal
rats. Other tissues (kidney, brain and skeletal muscle) were
evaluated for the same bioenergetic parameters, confirming that
this feature is exclusive to liver from diabetic GK rats.
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1. Introduction
Non-insulin dependent diabetes mellitus (NIDDM) is one
of the most common diseases spread over the world and is
associated with severe disturbances that spoil the life quality
of modern developed societies.
The Goto-Kakizaki (GK) rat has been raised as an animal
model of NIDDM. This animal is a spontaneously diabetic
rat, produced by selective inbreeding of Wistar rats with the
highest glucose values during oral glucose tolerance tests [1].
The GK rat exhibits a defective insulin secretion, and im-
paired glucose tolerance, but no obesity [2]. Furthermore, it
was shown that the impaired glucose induced insulin release in
islets from GK rats was associated with a perturbation of
mitochondrial oxidative events [3,4], suggesting the occurrence
of bioenergetic alterations at mitochondrial level.
Since some of the most important biochemical reactions
determining the metabolic disorders observed in diabetes are
localized in the mitochondria, the aim of the present study
was to evaluate possible alterations at the level of mitochon-
dria bioenergetics in diabetic GK rats as compared to control
Wistar rats. In this report, by comparing bioenergetic param-
eters from di¡erent mitochondrial preparations (liver, brain,
kidney and skeletal muscle), we clearly show that increased
ATPase activity and membrane potential are expressive of an
increased e⁄ciency in the oxidative phosphorylation of dia-
betic GK rats as compared with control animals and that this
feature is exclusive to the liver.
2. Materials and methods
2.1. Animals
Male spontaneously diabetic GK rats were from our colony (Labo-
ratory Animal Research Center, University Hospitals, Coimbra).
They were kept under controlled light and humidity conditions and
had free access to powdered rodent chow (diet C.R.F. 20, Charles
Rivers, France) and water. Control animals were normal male Wistar
rats of similar age (26 weeks), grown and kept under the same con-
ditions. The life span of GK rats equals that of normal Wistar rats.
2.2. Materials
All reagents and chemicals used were of the highest grade of purity
commercially available.
2.3. Preparation of liver mitochondria
Mitochondria were isolated from liver of male Wistar and GK rats
(26 weeks) by conventional methods [5], with slight modi¢cations [6].
2.4. Preparation of brain mitochondria
Crude mitochondrial preparations were obtained from brain ac-
cording to the method described by Dykens [7].
2.5. Preparation of kidney mitochondria
Mitochondria were extracted from a homogenate of rat kidney by
di¡erential centrifugation according to Cain and Skilleter [8].
2.6. Preparation of skeletal muscle mitochondria
Rat skeletal muscle mitochondria were prepared according to Bhat-
tacharya et al. [9] with minor modi¢cations.
2.7. Protein determination
Protein was determined by the Bradford method, using bovine se-
rum albumin as a standard [10,11].
2.8. Membrane potential (v8) measurements
The mitochondrial transmembrane potential was estimated by cal-
culating transmembrane distribution of TPP (tetraphenylphospho-
nium) with a TPP selective electrode prepared according to Kamo
et al. [12] using a calomel electrode as reference, as previously de-
scribed [13].
For titration with oligomycin, after addition of succinate mitochon-
dria developed a potential of about 3220 mV (negative inside). With
the addition of ADP, the potential dropped because ATP synthase
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uses v8 to phosphorylate ADP. After a short lag phase, when ADP
phosphorylation takes place, the transmembrane potential repolarized
close to the initial value. Successive additions of oligomycin aliquots
(0.2 Wg/mg protein) 2 min before ADP addition (0.12 mM), as indi-
cated in Fig. 1, progressively block a higher number of ATPase units
contributing to the observed decreased number of phosphorylation
cycles induced by successive ADP additions.
2.9. ATPase activity
For ATPase activity determination liver, skeletal muscle, kidney
and brain preparations were divided into aliquots and frozen in liquid
nitrogen for 1^7 days. At the time of use, each aliquot was freeze
thawed three times and maintained at 0‡C. ATPase activity (liver,
skeletal muscle, kidney and brain) was determined by monitoring
the pH change in association with ATP hydrolysis, as previously
described [14]. The reaction was carried out at 25‡ C, in 2 ml reaction
medium (130 mM sucrose, 50 mM KCl, 5 mM MgCl2, 0.5 mM
HEPES, 2 WM rotenone, pH 7.2) and freeze thawed mitochondria
(0.5 mg) were added. The reaction was initiated by the addition of
2 mM Mg-ATP; production of H was measured after an elapsed
time of 1 min from the start of the reactions, following calibrations of
the trace with aliquots of titrated HCl. The addition of oligomycin
(1 Wg/mg protein) to the medium completely abolished the production
of protons. Optimal assay conditions were the same in control Wistar
and GK rats.
Brain and kidney mitochondrial ATPase was calculated as the dif-
ference in ATPase activity measured in the presence of ouabain
(0.2 mM) and of ouabain plus oligomycin (1 Wg/ mg protein), as
previously described [15].
For kinetic studies, the concentration of ATP ranged from 25 WM
to 2 mM. The Km and Vmax values were determined from the Line-
weaver-Burk analysis.
2.10. Statistics
The results are presented as mean þ S.E.M. of the number of experi-
ments indicated and statistical signi¢cance was determined using
paired Student’s t-test.
3. Results
Energization and phosphorylation capacities of mitochon-
dria isolated from diabetic GK and non-diabetic Wistar rats
were investigated by following the transmembrane potential
(v8) developed by mitochondria upon succinate oxidation
(Table 1). The results show that the v8 values developed in
brain, kidney and skeletal muscle from GK rats (Table 1)
were similar to those determined in the same tissues from
control animals. Additionally, both the depolarization in-
duced by ADP and the repolarization rate showed no di¡er-
ence between GK and control rats (Table 1).
In contrast, v8 developed in liver of GK rats upon energ-
ization with substrate (Table 1) was signi¢cantly increased as
compared to controls (from 207.07 þ 2.36 mV in control to
219.17 þ 1.25 mV in GK). Depolarization induced by the ad-
Table 1
v8 determined in the presence of succinate as respiratory substrate
Condition Energization (mV) vADP (mV) Repolarization rate (% control)
Liver control 207.07 þ 2.36 (n = 11) 17.40 þ 1.10 (n = 11) 100.00 þ 3.94 (n = 9)
Liver GK 219.17 þ 1.25 (n = 9)* 16.08 þ 1.45 (n = 9) 182.34 þ 18.79 (n = 9)**
Brain control 177.9 þ 1.22 (n = 6) 22.8 þ 0.85 (n = 6) 100.0 þ 3.8 (n = 6)
Brain GK 177.4 þ 1.3 (n = 7) 21.8 þ 0.91 (n = 7) 105.2 þ 4.1 (n = 7)
Kidney control 196.5 þ 2.1 (n = 5) 44.8 þ 1.05 (n = 5) 100.0 þ 2.62 (n = 5)
Kidney GK 196.1 þ 2.35 (n = 6) 44.7 þ 1.21 (n = 6) 101.4 þ 3.21 (n = 5)
Smooth muscle control 203.3 þ 2.15 (n = 7) 32.0 þ 0.92 (n = 7) 100.0 þ 3.42 (n = 7)
Smooth muscle GK 202.3 þ 2.42 (n = 6) 33.6 þ 1.25 (n = 6) 98.7 þ 2.81 (n = 6)
Standard reaction medium (1 ml) was supplemented with mitochondria (1 mg) and 3 WM TPP and 2 WM rotenone. The energization of mito-
chondria was performed by addition of succinate. To induce phosphorylation, 30^40 nmol ADP was used.
Data are mean þ S.E.M. of the number of experiments indicated. Values statistically di¡erent from control: *P6 0.05; **P6 0.005.
Fig. 1. Titration with oligomycin of mitochondrial membrane potential. Where indicated, oligomycin (0.2 Wg/mg protein) and ADP (0.12 mM)
were added. The traces represent typical direct recordings from six independent experiments.
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dition of ADP was similar in liver of GK and controls
(17.4 þ 1.10 mV in control and 16.08 þ 1.45 mV in GK), the
lag phase preceding repolarization was shortened in the liver
of GK rats, but the repolarization rate was highly increased in
diabetic liver of GK rats (from 100 þ 3.94% in control to
182 þ 18.79% in GK).
To further explore and understand these ¢ndings, the ATP-
ase activity (Table 2) from liver, brain, kidney and skeletal
muscle of diabetic GK and control rats was evaluated. As
expected, ATPase activities from brain, kidney and skeletal
muscle from GK rats (Table 2) were similar to those deter-
mined in the same tissues from control animals, with the high-
est activity obtained in skeletal muscle.
A signi¢cantly increased ATPase activity was detected for
liver of GK (198.61 þ 14.91 nmol H/mg/min) as compared
with control animals (119.54 þ 17.06 nmol H/mg/min). This
increased ATPase activity explains the increased repolariza-
tion rate of mitochondria from diabetic liver of GK rat.
The improved performance of phosphorylation may be related
either to a higher e⁄ciency of F0F1-ATPase (increasing the
energy coupling) or to a large number of F0F1-ATPase units.
Substrate saturation curves for the control Wistar and dia-
betic GK rats appeared to be almost similar (data not shown).
However, when we determined the kinetic parameters for the
ATP hydrolysis (Table 3), we observes an identical Km for
both Wistar and GK liver mitochondrial ATPase
(87.35 þ 4.3 and 94.5 þ 5.3 WM, respectively in control and
GK), suggesting that the a⁄nity for substrate was not altered
in liver. In contrast, Vmax was increased in liver of diabetic
GK rats (from 80.3 þ 3.1 to 102.7 þ 5.8 nmol/min/mg, respec-
tively in control and GK), pointing out an increase in speci¢c
activity in liver mitochondrial ATPase. Kinetic properties of
ATPase determined in brain, kidney and skeletal muscle mi-
tochondria showed no signi¢cant di¡erences in Km and Vmax
values in GK rats as compared with control Wistar rats (data
not shown).
The observed di¡erences were further elucidated by titrating
the traces with pulses of oligomycin (Fig. 1). It is clear that
GK liver mitochondria require a larger number of oligomycin
pulses to completely abolish depolarization induced by succes-
sive additions of ADP. Therefore, GK liver mitochondria are
provided with extra ATPase units as compared with prepara-
tions derived from control Wistar rats.
4. Discussion
Mitochondria are provided with a variety of bioenergetic
functions mandatory for the regulation of intracellular aerobic
energy production. Alteration of bioenergetic activities may
have drastic consequences on cellular function through the
perturbation of energetic charge and balance of the cell.
A review of the literature of experimental diabetes produced
by treatment with streptozotocin or alloxan claims attention
for defects in mitochondrial function [16^18]. However, at
present, little is known about the mechanisms or the progres-
sion of these defects. The main di¡erence between the two
models (streptozotocin or alloxan induced and GK rats) is
that the ¢rst model is a drastic and severe model of NIDDM,
whereas the GK rat does not present severe complications of
the disease, being an appropriate model to study the events at
the onset of the disease.
Mitochondrial bioenergetic studies have not yet been car-
ried out in this model (GK rat). Our report for the ¢rst time
describes an increased e⁄ciency of the phosphorylative system
of GK liver mitochondria but not in other tissues like brain,
kidney and skeletal muscle.
Since some of the important biochemical reactions deter-
mining the metabolic disorders observed in diabetes are local-
ized in the hepatic mitochondria [16] and the liver is a central
organ in glucose homeostasis [19], the observed increased e⁄-
ciency in the phosphorylative system from GK rat liver mito-
chondria (presumably re£ecting a large number of F0F1-
ATPase units) could develop as a biochemical response or
adaptation to circumvent metabolic disturbances associated
with NIDDM. The signi¢cantly increased kinetic constant
(Vmax) determined for F0F1-ATPase from liver mitochondria
of GK rats, showing a higher speci¢c activity for the enzyme,
supports the hypothesis of increased e⁄ciency of the phos-
phorylative system in liver mitochondria of GK rats.
A possible explanation could be related to excess use of
ATP in some metabolic functions (e.g. pumping of ions or
other process) and the improved ATP synthesis would then
compensate the defect. In other words, an increased e⁄ciency
of oxidative phosphorylation is adequate to maintain an in-
creased turnover of ATP. According to our suggestion, a re-
cent paper from Zong-Chao et al. [20] showed that the uti-
lization of ATP (2.5^3-fold more in the GK than control
islets) may justify this increased e⁄ciency on mitochondrial
oxidative phosphorylation and suggested that the increased
turnover of ATP could be due to altered activity of mitochon-
drial F0F1-ATPase.
Further studies on this subject are being conducted in our
laboratory, in order to better elucidate the mechanisms in-
volved in the development of this disease.
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